Back to News
Market Impact: 0.35
What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call
Source: marketbeat.com
Corporate Guidance & OutlookCorporate EarningsHealthcare & BiotechCompany Fundamentals
Zimmer Biomet raised its 2026 sales growth and adjusted earnings outlook after third-quarter growth in hips, surgical specialties and technology offset continued weakness in its knee business. The article provides no updated figures for the outlook or segment growth.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
ZBH0.65
More News
- Here are the 2 big things we're watching in the stock market in the week ahead
- China AI bust threatens Xi’s ’Wall Street East’ ambitions
- As tech swoon roils market, US inflation data on tap
- Berkshire Hathaway speeds up stock buybacks, though profit falls
- Cabaletta Bio reports phase 1/2 data for autoimmune therapy
- Nvidia CEO Jensen Huang faces bipartisan congressional scrutiny over reported China spy link